MZF1 and SCAND1 high expression correlated with better prognoses in patients suffering from pancreatic cancer and head and neck cancers (Figure 6), suggesting that elevated SCAND1-MZF1 co-expression could inhibit EMT and invasive phenotypes in cancer. This evidence concerns the gene SCAND1 and familial pancreatic carcinoma.